CFAP61
gene geneOn this page
Also known as DKFZP434K156dJ1002M8.3CaM-IP3
Summary
CFAP61 (cilia and flagella associated protein 61, HGNC:15872) is a protein-coding gene on chromosome 20p11.23, encoding Cilia- and flagella-associated protein 61 (Q8NHU2). Involved in sperm flagellum assembly.
Acts upstream of or within sperm mitochondrial sheath assembly. Located in axoneme and sperm flagellum. Implicated in spermatogenic failure 84.
Source: NCBI Gene 26074 — automated summary from GO annotations (Alliance of Genome Resources).
At a glance
- GWAS associations: 8
- Clinical variants (ClinVar): 247 total — 7 pathogenic, 2 likely-pathogenic
- GTEx eGene: eQTL in 19 tissues, sQTL in 4 (q < 0.05)
- Phenotypes (HPO): 11
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 0.89 (unconstrained)
- MANE Select transcript:
NM_015585 - Notable: 247 clinical variants but no curated precision-oncology (CIViC) evidence yet
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15872 |
| Approved symbol | CFAP61 |
| Name | cilia and flagella associated protein 61 |
| Location | 20p11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZP434K156, dJ1002M8.3, CaM-IP3 |
| Ensembl gene | ENSG00000089101 |
| Ensembl biotype | protein_coding |
| OMIM | 620381 |
| Entrez | 26074 |
Gene structure
Transcript identifiers
Ensembl transcripts: 34 — 21 protein_coding, 6 protein_coding_CDS_not_defined, 4 nonsense_mediated_decay, 3 retained_intron
MANE Select: ENST00000245957
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 5, TSL 2: 2, TSL 3: 3, TSL 4: 4, TSL 5: 6
ENST00000245957, ENST00000340348, ENST00000377293, ENST00000377303, ENST00000377306, ENST00000377308, ENST00000389656, ENST00000431753, ENST00000442372, ENST00000451767, ENST00000468719, ENST00000469994, ENST00000472660, ENST00000475466, ENST00000476414, ENST00000486624, ENST00000488640, ENST00000493330, ENST00000494029, ENST00000497372, ENST00000674269, ENST00000674296, ENST00000674445, ENST00000674463, ENST00000884932, ENST00000884933, ENST00000884934, ENST00000884935, ENST00000884936, ENST00000884937, ENST00001128518, ENST00001128519, ENST00001128520, ENST00001133369
RefSeq mRNA: 2 — MANE Select: NM_015585
NM_001167816, NM_015585
CCDS: CCDS33447, CCDS54452
Canonical transcript exons
ENST00000245957 — 27 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001594211 | 20262956 | 20263130 |
| ENSE00001602021 | 20277166 | 20277458 |
| ENSE00003465164 | 20290300 | 20290391 |
| ENSE00003468439 | 20098655 | 20098814 |
| ENSE00003471017 | 20070854 | 20071004 |
| ENSE00003486942 | 20075189 | 20075256 |
| ENSE00003502373 | 20196570 | 20196776 |
| ENSE00003505335 | 20166397 | 20166436 |
| ENSE00003505730 | 20191342 | 20191419 |
| ENSE00003507903 | 20251595 | 20251763 |
| ENSE00003536236 | 20169321 | 20169460 |
| ENSE00003543813 | 20075489 | 20075615 |
| ENSE00003545995 | 20142857 | 20142948 |
| ENSE00003555646 | 20246117 | 20246215 |
| ENSE00003562412 | 20298181 | 20298386 |
| ENSE00003569193 | 20341831 | 20341921 |
| ENSE00003575692 | 20187930 | 20188056 |
| ENSE00003589138 | 20159370 | 20159444 |
| ENSE00003622209 | 20164050 | 20164228 |
| ENSE00003648116 | 20090844 | 20090976 |
| ENSE00003670284 | 20056618 | 20056796 |
| ENSE00003673658 | 20288609 | 20288936 |
| ENSE00003676460 | 20199768 | 20199902 |
| ENSE00003676821 | 20074302 | 20074378 |
| ENSE00003690727 | 20360210 | 20360698 |
| ENSE00003758687 | 20228249 | 20228376 |
| ENSE00003842071 | 20052532 | 20052591 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 95.53.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9286 / max 111.7762, expressed in 240 samples.
Highest expression (Bgee): buccal mucosa cell, gastrocnemius, uterine tube, muscle of leg, primordial germ cell in gonad.
Genetic regulation across tissues (GTEx eQTL / sQTL)
CFAP61 is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 19 tissues and its splicing (sQTL) in 4 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
showing 20 of 23 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Muscle Skeletal | sqtl | 3.1e-54 | +0.82 | 20:20330695:A:G |
| Thyroid | eqtl | 1.0e-25 | +0.64 | 20:20045783:A:T |
| Muscle Skeletal | eqtl | 3.8e-19 | -0.33 | 20:20086057:C:T |
| Artery Aorta | eqtl | 7.6e-17 | -0.52 | 20:20086057:C:T |
| Brain Frontal Cortex BA9 | eqtl | 3.0e-14 | -0.53 | 20:20052723:C:G |
| Testis | eqtl | 2.9e-11 | -0.15 | 20:20020142:T:A |
| Brain Cortex | eqtl | 3.7e-10 | -0.51 | 20:20052779:G:A |
| Brain Anterior cingulate cortex BA24 | eqtl | 1.6e-08 | -0.40 | 20:20036999:T:C |
| Skin Sun Exposed Lower leg | eqtl | 3.0e-08 | -0.30 | 20:20103305:T:C |
| Testis | sqtl | 1.6e-06 | +0.68 | 20:20067209:A:G |
| Brain Hippocampus | eqtl | 3.7e-06 | -0.27 | 20:20063329:T:C |
| Brain Nucleus accumbens basal ganglia | eqtl | 7.4e-05 | -0.22 | 20:20034548:T:TAAAC |
| Brain Substantia nigra | eqtl | 1.9e-04 | +1.37 | 20:20084679:G:A |
| Heart Atrial Appendage | eqtl | 3.1e-04 | +0.30 | 20:20091770:C:T |
| Pituitary | eqtl | 6.7e-04 | -0.25 | 20:20086057:C:T |
| Heart Left Ventricle | sqtl | 1.0e-03 | +0.31 | 20:20322732:G:A |
| Brain Caudate basal ganglia | eqtl | 2.1e-03 | -0.14 | 20:20078348:G:A |
| Lung | eqtl | 2.9e-03 | -0.36 | 20:20931745:C:T |
| Brain Spinal cord cervical c-1 | eqtl | 6.3e-03 | +1.75 | 20:20084679:G:A |
| Skin Not Sun Exposed Suprapubic | eqtl | 6.7e-03 | +0.44 | 20:20120512:T:C |
FANTOM5 promoters
6 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 183765 | 0.5234 | 173 |
| 183768 | 0.2696 | 49 |
| 183769 | 0.0493 | 14 |
| 183767 | 0.0370 | 19 |
| 183766 | 0.0335 | 23 |
| 183771 | 0.0158 | 4 |
Top tissues by expression
showing 100 of 249 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 95.53 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.83 | gold quality |
| right uterine tube | UBERON:0001302 | 92.51 | gold quality |
| muscle of leg | UBERON:0001383 | 91.69 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.34 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 89.40 | gold quality |
| left testis | UBERON:0004533 | 87.76 | gold quality |
| right testis | UBERON:0004534 | 87.32 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.70 | gold quality |
| heart left ventricle | UBERON:0002084 | 84.97 | gold quality |
| testis | UBERON:0000473 | 84.67 | gold quality |
| apex of heart | UBERON:0002098 | 84.46 | gold quality |
| cardiac ventricle | UBERON:0002082 | 84.02 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 83.56 | gold quality |
| bronchial epithelial cell | CL:0002328 | 81.70 | gold quality |
| bronchus | UBERON:0002185 | 79.86 | gold quality |
| adenohypophysis | UBERON:0002196 | 79.52 | gold quality |
| pituitary gland | UBERON:0000007 | 79.44 | gold quality |
| tibialis anterior | UBERON:0001385 | 75.27 | silver quality |
| islet of Langerhans | UBERON:0000006 | 73.11 | gold quality |
| secondary oocyte | CL:0000655 | 72.28 | gold quality |
| ventricular zone | UBERON:0003053 | 72.24 | gold quality |
| heart | UBERON:0000948 | 70.84 | gold quality |
| hypothalamus | UBERON:0001898 | 70.74 | gold quality |
| caudate nucleus | UBERON:0001873 | 69.16 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 68.94 | gold quality |
| calcaneal tendon | UBERON:0003701 | 68.63 | gold quality |
| right lung | UBERON:0002167 | 68.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.11 | gold quality |
| nucleus accumbens | UBERON:0001882 | 68.02 | gold quality |
| deltoid | UBERON:0001476 | 67.87 | silver quality |
| left ventricle myocardium | UBERON:0006566 | 66.59 | gold quality |
| fallopian tube | UBERON:0003889 | 66.51 | gold quality |
| muscle tissue | UBERON:0002385 | 65.91 | gold quality |
| putamen | UBERON:0001874 | 65.06 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 64.78 | gold quality |
| right frontal lobe | UBERON:0002810 | 64.50 | gold quality |
| heart right ventricle | UBERON:0002080 | 64.34 | silver quality |
| pancreatic ductal cell | CL:0002079 | 64.25 | silver quality |
| cortical plate | UBERON:0005343 | 63.88 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 63.66 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 63.32 | gold quality |
| forebrain | UBERON:0001890 | 62.99 | gold quality |
| upper arm skin | UBERON:0004263 | 62.96 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 62.80 | gold quality |
| neocortex | UBERON:0001950 | 62.43 | gold quality |
| frontal cortex | UBERON:0001870 | 62.32 | gold quality |
| brain | UBERON:0000955 | 62.03 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 61.78 | gold quality |
| skin of leg | UBERON:0001511 | 61.68 | gold quality |
| myocardium | UBERON:0002349 | 61.68 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 61.29 | gold quality |
| ganglionic eminence | UBERON:0004023 | 61.18 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 61.10 | gold quality |
| cerebellar cortex | UBERON:0002129 | 61.09 | gold quality |
| amygdala | UBERON:0001876 | 60.91 | gold quality |
| substantia nigra | UBERON:0002038 | 60.67 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 60.04 | gold quality |
| spinal cord | UBERON:0002240 | 59.97 | gold quality |
| cerebral cortex | UBERON:0000956 | 59.85 | gold quality |
| cerebellum | UBERON:0002037 | 59.83 | gold quality |
| caput epididymis | UBERON:0004358 | 59.68 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 59.54 | gold quality |
| tendon | UBERON:0000043 | 59.23 | gold quality |
| biceps brachii | UBERON:0001507 | 59.14 | silver quality |
| oviduct epithelium | UBERON:0004804 | 59.10 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 59.01 | silver quality |
| primary visual cortex | UBERON:0002436 | 58.96 | gold quality |
| midbrain | UBERON:0001891 | 58.70 | gold quality |
| upper leg skin | UBERON:0004262 | 58.63 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 58.63 | gold quality |
| corpus callosum | UBERON:0002336 | 58.56 | gold quality |
| Ammon’s horn | UBERON:0001954 | 57.72 | gold quality |
| thyroid gland | UBERON:0002046 | 57.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 57.36 | gold quality |
| right atrium auricular region | UBERON:0006631 | 57.34 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 57.32 | gold quality |
| endocervix | UBERON:0000458 | 57.31 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 57.26 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 56.95 | gold quality |
| cardiac atrium | UBERON:0002081 | 56.94 | gold quality |
| zone of skin | UBERON:0000014 | 56.90 | gold quality |
| granulocyte | CL:0000094 | 56.68 | gold quality |
| pancreas | UBERON:0001264 | 55.89 | gold quality |
| left uterine tube | UBERON:0001303 | 55.82 | gold quality |
| upper lobe of lung | UBERON:0008948 | 55.81 | gold quality |
| skin of abdomen | UBERON:0001416 | 55.73 | gold quality |
| substantia nigra pars reticulata | UBERON:0001966 | 55.56 | gold quality |
| lung | UBERON:0002048 | 55.20 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 55.17 | gold quality |
| anatomical system | UBERON:0000467 | 55.17 | gold quality |
| multicellular organism | UBERON:0000468 | 54.96 | gold quality |
| material anatomical entity | UBERON:0000465 | 54.94 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 54.34 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 54.30 | gold quality |
| pericardium | UBERON:0002407 | 54.22 | gold quality |
| cerebellar vermis | UBERON:0004720 | 54.18 | gold quality |
| occipital lobe | UBERON:0002021 | 54.17 | gold quality |
| temporal lobe | UBERON:0001871 | 53.99 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.84 |
HPA expression
RNA tissue specificity: Tissue enhanced
showing 60 of 65 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM | Protein (IHC) |
|---|---|---|---|
| Choroid plexus | tissue | 37.2 | medium |
| Periaqueductal gray | tissue | 20.4 | |
| Cerebellum | tissue | 18.2 | not detected |
| Olfactory bulb | tissue | 14.7 | |
| Testis | tissue | 14.5 | medium |
| Basal ganglia | tissue | 13.5 | low |
| Hippocampal formation | tissue | 11.9 | |
| Heart muscle | tissue | 11.6 | low |
| Fallopian tube | tissue | 11.4 | high |
| Hypothalamus | tissue | 11.1 | |
| Septum | tissue | 10.0 | |
| Tongue | tissue | 9.5 | |
| Skeletal muscle | tissue | 9.4 | low |
| Corpus callosum | tissue | 8.9 | |
| Amygdala | tissue | 7.7 | |
| Pons | tissue | 7.5 | |
| Thalamus | tissue | 6.7 | |
| Ventral forebrain | tissue | 6.7 | |
| Nucleus accumbens | tissue | 6.4 | |
| Midbrain | tissue | 6.1 | |
| Medulla oblongata | tissue | 5.8 | |
| Substantia nigra | tissue | 5.8 | |
| Putamen | tissue | 5.7 | |
| Prefrontal cortex | tissue | 5.3 | |
| Cerebral cortex | tissue | 5.3 | not detected |
| Retrosplenial cortex | tissue | 5.0 | |
| Locus coeruleus | tissue | 4.8 | |
| Somatosensory cortex | tissue | 4.7 | |
| Superior colliculi | tissue | 4.4 | |
| Retrosplenial and cingulate cortex | tissue | 4.4 | |
| Temporal cortex | tissue | 4.4 | |
| Insular cortex | tissue | 4.4 | |
| Hippocampus | tissue | 4.2 | not detected |
| Entorhinal cortex | tissue | 4.1 | |
| Occipital cortex | tissue | 4.1 | |
| Motor cortex | tissue | 3.9 | |
| Postcentral gyrus | tissue | 3.4 | |
| Pituitary gland | tissue | 2.9 | |
| Spinal cord | tissue | 2.3 | |
| Frontal cortex | tissue | 2.0 | |
| Retina | tissue | 1.7 | |
| Caudate putamen | tissue | 1.6 | |
| Lung | tissue | 1.2 | not detected |
| Epididymis | tissue | 0.9 | |
| Thyroid gland | tissue | 0.7 | not detected |
| Kidney | tissue | 0.7 | not detected |
| Endometrium 1 | tissue | 0.6 | not detected |
| Adrenal gland | tissue | 0.6 | low |
| Parathyroid gland | tissue | 0.5 | not detected |
| Cervix | tissue | 0.4 | not detected |
| Pancreas | tissue | 0.3 | not detected |
| Prostate | tissue | 0.3 | not detected |
| Breast | tissue | 0.2 | not detected |
| Ovary | tissue | 0.2 | not detected |
| Seminal vesicle | tissue | 0.2 | not detected |
| Skin 1 | tissue | 0.1 | not detected |
| Lymph node | tissue | 0.1 | not detected |
| Stomach 1 | tissue | 0.1 | not detected |
| Vagina | tissue | 0.1 | not detected |
| Smooth muscle | tissue | 0.1 | not detected |
Brain sub-regions (HPA Brain Atlas): detected in 190; highest nTPM — Periaquaductal grey, lateral (18.4), Nucleus tractus solitarii (14.0), Dorsal hippocampus (11.9), Cervical spinal cord, central gray (11.8), Periaquaductal grey, dorsal (10.9).
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
Targeting CFAP61 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific).
24 miRNAs:
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-9718 | 99.94 | 68.91 | 918 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-138-2-3P | 98.91 | 68.33 | 1643 |
| HSA-MIR-873-5P | 98.84 | 66.90 | 1348 |
| HSA-MIR-603 | 98.58 | 68.28 | 1603 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-5187-5P | 98.54 | 67.94 | 952 |
| HSA-MIR-628-5P | 98.36 | 67.74 | 844 |
| HSA-MIR-4778-5P | 97.96 | 68.06 | 1634 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-6728-5P | 97.79 | 66.33 | 891 |
| HSA-MIR-3116 | 97.07 | 65.78 | 1324 |
| HSA-MIR-4695-3P | 96.71 | 67.21 | 836 |
Functional genomics
gnomAD constraint: pLI 3.88e-22, LOEUF 0.892, missense Z 0.976 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000245957 — one region, missense o/e 0.97.
Literature-anchored findings (GeneRIF, showing 4)
- CFAP61 is required for sperm flagellum formation and male fertility in human and mouse. (PMID:34792097)
- Biallelic CFAP61 variants cause male infertility in humans and mice with severe oligoasthenoteratozoospermia. (PMID:35387802)
- CFAP61 knockdown aggravates male infertility by inhibiting testosterone secretion by Leydig cells via the MAPK/COX-2 pathway. (PMID:37982895)
- Identification of a novel CFAP61 homozygous splicing variant associated with multiple morphological abnormalities of the flagella. (PMID:38775994)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:zfos-223e1.2 | ENSDARG00000079997 |
| mus_musculus | Cfap61 | ENSMUSG00000037143 |
| rattus_norvegicus | Cfap61 | ENSRNOG00000011028 |
| drosophila_melanogaster | CG30268 | FBGN0050268 |
| drosophila_melanogaster | CG30275 | FBGN0050275 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1926024) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 18 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| male infertility | 3 |
| oligozoospermia | 2 |
| absent sperm flagellum | 2 |
| abnormal sperm flagellum morphology | 2 |
| coiled sperm flagellum | 2 |
| short sperm flagellum | 2 |
| abnormal sperm axoneme morphology | 2 |
| abnormal spermiogenesis | 1 |
| asthenozoospermia | 1 |
| increased blood urea nitrogen level | 1 |
| kinked sperm flagellum | 1 |
| thick sperm flagellum | 1 |
| decreased bone mineral content | 1 |
| increased testis apoptosis | 1 |
| decreased sperm progressive motility | 1 |
| immotile sperm | 1 |
| abnormal outer dense fiber morphology | 1 |
| abnormal sperm radial spoke morphology | 1 |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| INSM1 | protein-coding | 3642 |
| CFAP61-AS1 | ncRNA | 101929575 |
| CRNKL1 | protein-coding | 51340 |
| RALGAPA2 | protein-coding | 57186 |
| NAA20 | protein-coding | 51126 |
| RIN2 | protein-coding | 54453 |
| SLC24A3-AS1 | ncRNA | 100130264 |
| SLC24A3 | protein-coding | 57419 |
Protein
Protein identifiers
Cilia- and flagella-associated protein 61 — Q8NHU2 (reviewed: Q8NHU2)
All UniProt accessions (10): A0A6I8PIN3, A0A6I8PRQ8, C9J610, C9JA66, C9JHE8, C9JMV0, Q8NHU2, F8W6E2, F8WDF5, H0Y3Y7
UniProt curated annotations — full annotation on UniProt →
Function. Involved in sperm flagellum assembly. Plays an essential role in the formation of the radial spokes in flagellum axoneme.
Subunit / interactions. Component of axonemal radial spokes, the protein complexes that link the outer microtubule doublets with the central pair of microtubules. Interacts with CFAP91/MAATS1, ODAD2/ARMC4, RSPH3A, ROPN1, ROPN1L and RSPH9. Interacts with DYNLT1, DYNC1I2 and TUBB3. Interacts with WDR35, IFT22 and IFT81. Interacts with CFAP70.
Subcellular location. Cytoplasm. Cytoskeleton. Flagellum axoneme. Cilium axoneme. Cell projection. Cilium.
Disease relevance. Spermatogenic failure 84 (SPGF84) [MIM:620409] An autosomal recessive male infertility disorder characterized by multiple morphologic abnormalities of the sperm flagella, resulting in severely reduced motility. Some patients also have a reduced sperm count. The disease is caused by variants affecting the gene represented in this entry.
Miscellaneous. Created from a fragment entry and may await further characterization.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NHU2-1 | 1 | yes |
| Q8NHU2-3 | 3 | |
| Q8NHU2-4 | 4 | |
| Q8NHU2-5 | 5 | |
| Q8NHU2-6 | 6 |
RefSeq proteins (2): NP_001161288, NP_056400* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR032151 | CFAP61_N | Domain |
| IPR036188 | FAD/NAD-bd_sf | Homologous_superfamily |
| IPR038884 | CFAP61 | Family |
| IPR056299 | CFAP61_dimer | Domain |
Pfam: PF16092, PF23150
UniProt features (25 total): sequence variant 12, splice variant 8, sequence conflict 2, chain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
1 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 8J07 | 96nm repeat of human respiratory doublet microtubule and associated axonemal complexes | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NHU2-F1 | 84.86 | 0.57 |
Human Protein Atlas
Protein class: Predicted membrane proteins, Predicted intracellular proteins, UniProt - Evidence at transcript level
Protein evidence: Evidence at protein level
Subcellular location (HPA, imaging): cytosol; principal piece; nucleoplasm
Antibody reliability (HPA): IH approved · IF approved
Function
Pathways and Gene Ontology
Reactome pathways
0 curated (TAS) of 0; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
MSigDB gene sets: 101 (showing top):
GOBP_MALE_GAMETE_GENERATION, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_MOTILE_CILIUM_ASSEMBLY, GOBP_CELL_PROJECTION_ORGANIZATION, MODULE_95, GOCC_CYTOPLASMIC_REGION, GOCC_MOTILE_CILIUM, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOCC_CILIUM, chr20p11
GO Biological Process (5): cilium movement (GO:0003341), flagellated sperm motility (GO:0030317), cilium organization (GO:0044782), sperm flagellum assembly (GO:0120316), sperm mitochondrial sheath assembly (GO:0120317)
GO Cellular Component (6): axoneme (GO:0005930), motile cilium (GO:0031514), sperm flagellum (GO:0036126), radial spoke stalk (GO:0001536), cytoskeleton (GO:0005856), cilium (GO:0005929)
GO top-level categories
24 GO namespaces:
| Category | Terms |
|---|---|
| microtubule-based movement | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| organelle organization | 1 |
| plasma membrane bounded cell projection organization | 1 |
| developmental process involved in reproduction | 1 |
| spermatid development | 1 |
| flagellated sperm motility | 1 |
| motile cilium assembly | 1 |
| cellular component assembly | 1 |
| sperm flagellum assembly | 1 |
| cytoskeleton | 1 |
| microtubule | 1 |
| ciliary plasm | 1 |
| cellular anatomical structure | 1 |
| cilium | 1 |
| 9+2 motile cilium | 1 |
| radial spoke | 1 |
| protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 5 of 11 annotations. The rest are phylogenetic / computational / electronic (IEA).
5 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| flagellated sperm motility | BP | mutant phenotype |
| sperm flagellum assembly | BP | mutant phenotype |
| sperm mitochondrial sheath assembly | BP | mutant phenotype |
| axoneme | CC | direct assay |
| sperm flagellum | CC | direct assay |
Protein interactions and networks
STRING
showing 15 of 1,072 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CFAP61 | CFAP91 | Q7Z4T9 | 745 |
| CFAP61 | CFAP251 | Q8TBY9 | 716 |
| CFAP61 | CFAP70 | Q5T0N1 | 658 |
| CFAP61 | RSPH3 | Q86UC2 | 636 |
| CFAP61 | CFAP58 | Q5T655 | 629 |
| CFAP61 | NAA20 | P61599 | 618 |
| CFAP61 | CFAP206 | Q8IYR0 | 603 |
| CFAP61 | CRNKL1 | Q9BZJ0 | 602 |
| CFAP61 | CFAP43 | Q8NDM7 | 600 |
| CFAP61 | SPMIP1 | A0A1B0GUX0 | 597 |
| CFAP61 | CFAP44 | Q96MT7 | 595 |
| CFAP61 | SPMAP2L | P0DJG4 | 588 |
| CFAP61 | RSPH9 | Q9H1X1 | 574 |
| CFAP61 | DNAH1 | Q9P2D7 | 555 |
| CFAP61 | RSPH1 | Q8WYR4 | 527 |
IntAct
BioGRID (3 interactions; top human partners by supporting records): ATP6V0A1 (Cross-Linking-MS (XL-MS)), PARK2 (Affinity Capture-MS), PARP10 (Proximity Label-MS)
Disease & clinical
Genetic variants
Variant evidence for CFAP61: 247 ClinVar records (9 pathogenic / likely pathogenic); 8 GWAS associations. Per-variant detail is on Sugi Variant.
ClinVar
247 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 7 |
| Likely pathogenic | 2 |
| Uncertain significance | 197 |
| Likely benign | 17 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (9)
Showing all 9 pathogenic / likely-pathogenic ClinVar records, ranked by ClinVar review status (expert panel → multiple submitters → single submitter), then by number of submitting labs.
| Variant ID | HGVS | Classification | Review | Submitters |
|---|---|---|---|---|
| 2504102 | NM_015585.4(CFAP61):c.847C>T (p.Arg283Ter) | Pathogenic | criteria provided, single submitter | 2 |
| 4850446 | NM_015585.4(CFAP61):c.3125-1G>C | Likely pathogenic | criteria provided, single submitter | 1 |
| 4853824 | NM_015585.4(CFAP61):c.2264T>C (p.Val755Ala) | Likely pathogenic | criteria provided, single submitter | 1 |
| 1526686 | GRCh37/hg19 20p11.23-11.22(chr20:19292925-22187397)x1 | Pathogenic | criteria provided, single submitter | 1 |
| 2504100 | NM_015585.4(CFAP61):c.143+5G>A | Pathogenic | no assertion criteria provided | 1 |
| 2504101 | NM_015585.4(CFAP61):c.452_453del (p.Ile151fs) | Pathogenic | no assertion criteria provided | 1 |
| 2504104 | NM_015585.4(CFAP61):c.2911G>A (p.Asp971Asn) | Pathogenic | no assertion criteria provided | 1 |
| 2504105 | NM_015585.4(CFAP61):c.144-2A>G | Pathogenic | no assertion criteria provided | 1 |
| 2504106 | NM_015585.4(CFAP61):c.1666G>A (p.Gly556Arg) | Pathogenic | no assertion criteria provided | 1 |
Per-variant reference — Sugi Variant
Explore CFAP61’s pathogenic and likely-pathogenic variants individually — each with its ClinVar classification and conditions, applied ACMG criteria (ClinGen expert panel, where curated), the calibrated in-silico predictors (AlphaMissense, REVEL, SaProt, conservation), gnomAD frequency, and the predictor-disagreement QC signal — on Sugi Variant.
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 42 predictions of 2,910):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 20:20071005–20071006 | donor_loss | 1.0000 | 5 |
| 20:20074297 | acceptor_gain | 1.0000 | |
| 20:20074300–20074301 | acceptor_loss | 1.0000 | 6 |
| 20:20074379–20074380 | donor_loss | 1.0000 | 5 |
| 20:20164170 | donor_gain | 1.0000 | |
| 20:20187928–20187929 | acceptor_loss | 1.0000 | 5 |
| 20:20188057–20188058 | donor_loss | 1.0000 | 4 |
| 20:20196777–20196778 | donor_loss | 1.0000 | 5 |
| 20:20251764–20251765 | donor_loss | 1.0000 | 5 |
| 20:20263131–20263132 | donor_loss | 1.0000 | 5 |
AlphaMissense
2,107 missense substitutions predicted likely pathogenic (of 8,230 scored), across 625 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| D192 | 8 | 0.974 | 0.990 |
| D72 | 8 | 0.934 | 0.980 |
| D1154 | 8 | 0.933 | 0.971 |
| F104 | 8 | 0.930 | 0.991 |
| F154 | 8 | 0.905 | 0.982 |
| H1153 | 8 | 0.901 | 0.948 |
| D23 | 8 | 0.898 | 0.954 |
| F920 | 8 | 0.898 | 0.988 |
| D272 | 8 | 0.869 | 0.942 |
| D194 | 8 | 0.850 | 0.921 |
| D405 | 8 | 0.839 | 0.927 |
| F241 | 8 | 0.831 | 0.985 |
| F1087 | 8 | 0.830 | 0.965 |
| H555 | 8 | 0.816 | 0.946 |
| D473 | 8 | 0.814 | 0.858 |
| M1230 | 8 | 0.801 | 0.909 |
| F1143 | 8 | 0.790 | 0.979 |
| F70 | 8 | 0.773 | 0.986 |
| D1158 | 8 | 0.749 | 0.853 |
| D493 | 8 | 0.747 | 0.855 |
HPA cancer prognostics
RNA cancer specificity: Cancer enhanced (Glioblastoma Multiforme)
Disease associations
OMIM: gene MIM:620381 | disease phenotypes: MIM:620409
GenCC curated gene-disease
Mondo (2): spermatogenic failure 84 (MONDO:0957301), situs inversus (MONDO:0010029)
Orphanet (1): Situs inversus totalis (Orphanet:101063)
HPO phenotypes
11 phenotypes (HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000798 | Oligozoospermia |
| HP:0003251 | Male infertility |
| HP:0011462 | Young adult onset |
| HP:0012207 | Reduced sperm motility |
| HP:0032558 | Absent sperm flagella |
| HP:0032559 | Short sperm flagella |
| HP:0032560 | Coiled sperm flagella |
| HP:0033393 | Irregularly shaped sperm tail |
| HP:0034011 | Reduced progressive sperm motility |
| HP:0034811 | Bent sperm flagella |
GWAS associations
8 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST90000025_84 | Appendicular lean mass | 5e-20 |
| GCST90002399_185 | Neutrophil percentage of white cells | 8e-13 |
| GCST90000025_85 | Appendicular lean mass | 5e-12 |
| GCST90002389_478 | Lymphocyte percentage of white cells | 1e-10 |
| GCST004141_1 | Body fat mass | 2e-9 |
| GCST007576_65 | Chronotype | 2e-8 |
| GCST010314_6 | Serum omega-6 to omega-3 polyunsaturated fatty acid ratio in metabolic syndrome | 8e-6 |
| GCST008163_591 | Height | 9e-6 |
EFO canonical traits (from GWAS)
5 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0008328 | chronotype measurement |
| EFO:0010732 | omega-6:omega-3 polyunsaturated fatty acid ratio |
| EFO:0004980 | appendicular lean mass |
| EFO:0007993 | lymphocyte percentage of leukocytes |
| EFO:0007990 | neutrophil percentage of leukocytes |
MeSH disease descriptors
1 disease descriptors:
| Descriptor | Name | Tree numbers |
|---|---|---|
| D012857 | Situs Inversus | C16.131.810 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases mutagenesis, affects methylation | 2 |
| bisphenol F | decreases methylation, affects cotreatment | 1 |
| bisphenol A | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| aflatoxin B2 | increases methylation | 1 |
| tebuconazole | decreases expression | 1 |
| bisphenol S | increases methylation | 1 |
| Fulvestrant | affects cotreatment, decreases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Methylcholanthrene | increases reaction, affects binding | 1 |
| Rotenone | increases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Tunicamycin | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
1 trials:
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00608556 | Not specified | COMPLETED | Dyskinesia, Heterotaxy and Congenital Heart Disease |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): situs inversus, spermatogenic failure 84